Opinion

Taxpayers Aren’t Propping Up Big Pharma

Like your iPhone? Federal officials designed it. Couldn’t live without the Internet? Thank Uncle Sam—he invented it. Sick and need a new medicine? Don’t worry—the government is here to help.
Taxpayers Aren’t Propping Up Big Pharma
Aerial photograph from the north of the Mark O. Hatfield Clinical Research Center on the National Institutes of Health in Bethesda, Md., in 2008. NIH, Public Domain
|Updated:

Like your iPhone? Federal officials designed it. Couldn’t live without the Internet? Thank Uncle Sam—he invented it. Sick and need a new medicine? Don’t worry—the government is here to help.

This fantastical line of thinking—that because the government funded basic, early-stage research, it can claim credit for a final product decades later—underpins the latest calls for more federal control of drug prices. Such calls are grossly ill-informed and demonstrate a deep misunderstanding of the drug development process.

The latest calls for more federal control of drug prices are grossly ill-informed and demonstrate a deep misunderstanding of the drug development process.
Sally C. Pipes
Sally C. Pipes
Author
Sally C. Pipes is president, CEO, and the Thomas W. Smith fellow in healthcare policy at the Pacific Research Institute. Her latest book is "False Premise, False Promise: The Disastrous Reality of Medicare for All," (Encounter 2020). Follow her on Twitter @sallypipes
Related Topics